Cargando…

Familial Pancreatic Cancer: To Screen or not to Screen?

Detalles Bibliográficos
Autores principales:	Vasen, Hans F.A., Bartsch, Detlef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703731/ https://www.ncbi.nlm.nih.gov/pubmed/26844259 http://dx.doi.org/10.1016/j.ebiom.2015.12.014

Ejemplares similares

Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations
por: Nielsen, Maartje, et al.
Publicado: (2007)

German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program
por: Franke, Frederike S., et al.
Publicado: (2018)

Screening for pancreatic cancer in individuals with genetic susceptibility
por: Grützmann, Robert, et al.
Publicado: (2023)

The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2021)

Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer
por: Ibrahim, Isaura S., et al.
Publicado: (2016)

Prostate Cancer – To screen, or not to screen, is that the question?
por: Rosser, Charles J
Publicado: (2008)

Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?
por: Henneman, Lidewij, et al.
Publicado: (2015)

Pancreatic cancer screening in high-risk individuals with genetic susceptibility
por: Andersson, Roland, et al.
Publicado: (2023)

When to screen and not to screen
por: Cruickshanks, Nichola
Publicado: (2014)

Family substance use screening: less to hide, more to gain
por: Mannelli, Paolo, et al.
Publicado: (2016)

Familial Pancreatic Cancer and the Future of Directed Screening
por: Welinsky, Sara, et al.
Publicado: (2017)

Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers
por: Ibrahim, Isaura S, et al.
Publicado: (2019)

Commentary: Screening of screen time in children
por: Sainani, Ashwin
Publicado: (2022)

At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review
por: van Hoefen Wijsard, Milo, et al.
Publicado: (2021)

Lung cancer screening—Marching along …
por: Fong, Kwun M., et al.
Publicado: (2022)

Characteristics of familial pancreatic cancer families with additional colorectal carcinoma
por: Lehman, Bettina, et al.
Publicado: (2023)

Improved blood tests for cancer screening: general or specific?
por: Cree, Ian A
Publicado: (2011)

Statistical analysis and decision making in cancer screening
por: Habbema, Dik
Publicado: (2018)

Misinformation and Facts about Breast Cancer Screening
por: Kopans, Daniel B.
Publicado: (2022)

Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European Families
por: Slater, Emily, et al.
Publicado: (2007)

Gestational Diabetes Mellitus: To Screen or Not to Screen?: Is this really still a question?
por: Simmons, David, et al.
Publicado: (2013)

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families
por: Peelen, T, et al.
Publicado: (2000)

Ethnicity and prostate cancer: the way to solve the screening problem?
por: Bokhorst, Leonard P., et al.
Publicado: (2015)

Screening for cervical cancer: when theory meets reality
por: Nygård, Mari
Publicado: (2011)

The More, the Better: Is This True in Endoscopy for Gastric Cancer Screening?
por: Jeon, Seong Woo
Publicado: (2018)

Lung cancer screening guidelines are clear but are they being followed?
por: Olazagasti, Coral, et al.
Publicado: (2020)

Methicillin-resistant Staphylococcus aureus carriage at ICU admission: to screen (rapidly) or not to screen?
por: Lucet, Jean-Christophe
Publicado: (2012)

The NOD2 3020insC Mutation and The Risk of Familial Pancreatic Cancer?
por: Nej, Katarzyna, et al.
Publicado: (2004)

Personalized cancer screening: helping primary care rise to the challenge
por: Selby, Kevin, et al.
Publicado: (2018)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Measuring the psychosocial consequences of screening
por: Brodersen, John, et al.
Publicado: (2007)

Mammographic screening and mammographic patterns
por: Day, Nick, et al.
Publicado: (2000)

Universal screening: To do or not to do
por: Chatterjee, Samrat
Publicado: (2018)

Screen “play” for drug discovery
por: Narla, Anupama, et al.
Publicado: (2022)

Cost-Effective Screening for Breast Cancer Worldwide: Current State and Future Directions
por: Sarvazyan, A., et al.
Publicado: (2008)

Screening For Colorectal Cancer in the Age of Simulation Models: A Historical Lens
por: Phillips, Christopher J., et al.
Publicado: (2020)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities
por: Nodora, Jesse N, et al.
Publicado: (2020)

Novel Method for Screening Colorectal Neoplasm
por: Onodera, Hisashi
Publicado: (2015)

Screening and overdiagnosis: public health implications
por: Bulliard, Jean-Luc, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n5ugbiu6js8abukqd87s9gksr1